Research News

October 21, 2020
Moncef Slaoui, PhD, MBA, chief adviser for the COVID-19 vaccine development initiative Operation Warp Speed, visited GW on Oct. 21 to raise awareness for the national vaccine development efforts, encourage greater participation in the clinical trials and recognize GW for exceeding its enrollment…
October 19, 2020
The National Institutes of Health has awarded $1.6 million to researchers at SMHS for research on hormonal control of HIV latency.
October 5, 2020
It’s hard to recall a more important time for groundbreaking scientific research when it comes to the health and safety of the United States than in the past six months; by October the country had recorded more than 7 million cases of the novel coronavirus, and the global toll passed 1 million…
September 14, 2020
Four young researchers at the GW School of Medicine and Health Sciences were selected as fellows to the recently awarded five-year National Cancer Institute T32 Training Grant.
September 8, 2020
The retrospective study from a team at GW found that spironolactone may be safe to treat female pattern hair loss in breast cancer survivors.
August 25, 2020
Investigators at SMHS received a $1.2 million grant from Wellcome Trust to produce a controlled human hookworm infection model and establish a hookworm vaccine challenge model for two of the most advanced hookworm vaccine candidate antigens in endemic areas.
August 24, 2020
Timothy Harlan, MD, co-authored an article in The British Journal arguing for increased of "food is medicine" interventions in the health care system.
August 12, 2020
Alberto Bosque, PhD, MBA, assistant professor of microbiology, immunology, and tropical medicine, and his research team published in PLOS Pathogens finding a multiple sclerosis drug may be used to block HIV infection and reduce the latent reservoir.
August 4, 2020
 Alejandro Villagra, PhD, assistant professor of biochemistry and molecular medicine, and his research team published a new study in Cancer Research, finding the genetic modifier HDAC6 controls tumor growth and halts metastasis in triple-negative breast cancer in vivo.
August 4, 2020
Juan Reyes, MD, and Shant Ayanian, MD, both assistant professors of medicine, published research in the journal Future Medicine, finding five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients.